Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04902911 · ClinicalTrials.gov registry record
Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold)
A clinical trial, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- 91
- Enrollment target
NCT04902911 is a clinical trial that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 91 participants.
The verdict
NCT04902911 was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- 91 participants
- Enrollment target
Study Summary
This clinical study is designed to test the efficacy of the Novir 2019-nCoV Immunoglobulin M/Immunoglobulin G Antibody Test in a point-of-care setting to support the increasing need for rapid screening in the detection of antibodies. The study is performed on individuals who have no history of COVID-19 and no history of COVID immunization as well as individuals with history of COVID-19 that was diagnosed greater than 15 days. This is performed both through 3mL venous whole blood which is ran through an assay as well a point-of-care rapid test which is resulted in 10 minutes. Aiding in the rapid detection of COVID-19 antibodies.
Interventions
- DEVICE COVID-19 SARS-CoV IgG/IgM antibody rapid test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2021-04-13 |
| Est. Completion | 2022-08-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04902911
The ClinicalTrials.gov registry entry for NCT04902911 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 SARS-CoV IgG/IgM antibody rapid test is the first listed.
NCT04902911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04902911 about?
NCT04902911 is a clinical study titled "Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold)". This clinical study is designed to test the efficacy of the Novir 2019-nCoV Immunoglobulin M/Immunoglobulin G Antibody Test in a point-of-care setting to support the increasing need for rapid screening in the detection of antibodies. The study is performed on individuals who have no history of COVID...
What is the current status of trial NCT04902911?
This trial is currently terminated. The enrollment target is 91 participants. The study started on 2021-04-13. Estimated completion is 2022-08-17.
What interventions are being tested in trial NCT04902911?
The interventions under investigation include: COVID-19 SARS-CoV IgG/IgM antibody rapid test (DEVICE).
Who is sponsoring clinical trial NCT04902911?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.